Community Schedule

Enter at least 4 characters


  1. Back

Vaccinations

Download pdf

  1. Bacillus Calmette-Guerin vaccine
    1. Inj Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, vial with diluent
  2. COVID-19 vaccine
    1. Inj 10 mcg raxtozinameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap
    2. Inj 3 mcg raxtozinameran per 0.2 ml, 0.4 ml vial; infant vaccine, maroon cap
    3. Inj 30 mcg raxtozinameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap
    4. Inj 30 mcg raxtozinameran per 0.3 ml, 2.25 ml vial; adult vaccine, dark grey cap
    5. Inj 3 mcg bretovameran per 0.3 ml, 0.48 ml vial; infant vaccine, yellow cap
    6. Inj 10 mcg bretovameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap
    7. Inj 30 mcg bretovameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap
  3. Diphtheria, tetanus and pertussis vaccine
    1. Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagglutinin and 2.5 mcg pertactin in 0.5 ml prefilled syringe
  4. Diphtheria, tetanus, pertussis and polio vaccine
    1. Inj 30 IU diphtheria toxoid with 40 IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5ml syringe
  5. Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine
    1. Inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen, 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe
  6. Haemophilus influenzae type B vaccine
    1. Inj 10 mcg vial with diluent syringe
  7. Hepatitis A vaccine
    1. Inj 1440 ELISA units in 1 ml syringe
    2. Inj 720 ELISA units in 0.5 ml syringe
  8. Hepatitis B recombinant vaccine
    1. Inj 10 mcg per 0.5 ml prefilled syringe
    2. Inj 20 mcg per 1 ml prefilled syringe
  9. Human papillomavirus (6, 11, 16, 18, 31, 33, 45, 52 and 58) vaccine [HPV]
    1. Inj 270 mcg in 0.5 ml syringe
  10. Influenza vaccine
    1. Inj 60 mcg in 0.5 ml syringe (quadrivalent vaccine)
  11. Measles, mumps and rubella vaccine
    1. Inj, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml
  12. Meningococcal (groups A, C, Y and W-135) conjugate vaccine
    1. Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial
    2. Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier per 0.5 ml vial
  13. Meningococcal B multicomponent vaccine
    1. Inj 175 mcg per 0.5 ml prefilled syringe
  14. Pneumococcal (PCV13) conjugate vaccine
    1. Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5ml syringe
  15. Pneumococcal (PPV23) polysaccharide vaccine
    1. Inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype)
  16. Poliomyelitis vaccine
    1. Inj 80D antigen units in 0.5 ml syringe
  17. Rotavirus oral vaccine
    1. Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, squeezable tube
    2. Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator
  18. Varicella vaccine [Chickenpox vaccine]
    1. Inj 2000 PFU prefilled syringe plus vial
  19. Varicella zoster vaccine [Shingles vaccine]
    1. Inj 50 mcg per 0.5 ml vial plus vial



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.